期刊文献+

色素上皮衍生因子抑制糖基化终产物介导人肾小球系膜细胞糖基化终产物受体表达的研究 被引量:2

Pigment epithelium-derived factor inhibits advanced glycation end products-induced expression of receptor in human glomerular mesangial cells
原文传递
导出
摘要 目的 观察色素上皮衍生因子(PEDF)、晚期糖基化终产物受体(RAGE)的表达及重组PEDF对RAGE表达的抑制作用,探讨PEDF与DN的关系及对DN的保护作用. 方法 采用糖化小牛血清白蛋白(AGE-BSA)体外诱导人肾小球系膜细胞(HRMCs),Western blot及RT-PCR法分别检测RAGE、PEDF蛋白和mRNA表达. 结果 (1) AGE-BSA(100~400 mg/L)呈浓度梯度减少HRMCsPEDF表达(P<0.01),升高RAGE表达(P<0.01);(2)重组PEDF蛋白(5~40 nmol/L)呈浓度依赖性抑制AGE-BSA介导RAGE蛋白在HRMCs的表达(P<0.05). 结论 AGEs通过降低PEDF表达,增加RAGE表达参与DN的发生,PEDF可能通过抑制AGE-RAGE轴对DN发挥保护作用. Objective To observe the effects of advanced glyeation end-products (AGEs) on the expression of pigment epithelium-derived factor (PEDF) and on the expression of receptor of AGEs (RAGE) in the cultured human renal mesangial cells (HRMCs) and the effect of PEDF on diabetic nephropathy. Methods HRMCs were treated in vitro with AGE-bovine serum albumin (AGE-BSA) in the absense or presense of recombinant PEDF. Protein and mRNA of RAGE and PEDF were detected by Western hlot and RT-PCR method respectively. Results (1) AGE-BSA(100~400 mg/L) significantly increased RAGE expression and reduced the expression of PEDF in HRMCs(P〈0.01). (2) Recombinant PEDF (5~40 nmol/L) inhibited AGEs induced expression increase of RAGE in a dose-dependence manner (P〈0.05). Conclution AGEs increase RAGE expression and reduce PEDF expression in HRMCs, which may contribute to DN; PEDF inhibits AGEs-induced expression of RAGE, which could be a new therapeutic target in diabetic nephropathy.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第12期1132-1135,共4页 Chinese Journal of Diabetes
关键词 色素上皮衍生因子 晚期糖基化终产物 受体 糖尿病肾病 肾小球系膜细胞 Pigment epithelium-derived factor(PEDF) Advanced glyeation end products Receptor Diabetic nephropathy(DN) Renal mesangial cell
  • 相关文献

参考文献6

  • 1Cai J,Wu L,Qi X,et al.PEDF regulates vascular permeability by ar-secretase-mediated pathway.PLoS One,2011,6:e21164.
  • 2Wang JJ,Zhang SX,Mott R,et al.Anti-infliammatory effects of pigment epithelium-derived factor in diabetic nephropathy.Am J Physiol Renal Physiol,2008,294:F1166-F1173.
  • 3Yamagishi S.Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.Exp Gerontol,2011,46:217-224.
  • 4冯敏,黄国良,李健榕,钟林娜.糖基化终产物通过其受体诱导人肾小球系膜细胞表达CTGF和FN[J].中国病理生理杂志,2010,26(6):1156-1160. 被引量:5
  • 5Yamashi S,Matsui T,Nakamura K,et al.Pigment-epitheliumderived factor suppresses expression of receptor for advanced glycation end product in the eye of diabetic rats.Ophthalmic Res,2007,39:92-97.
  • 6Maeda S,Matsui T,Takeuchi M,et al.Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.Pharmacol Res,2010,11:1-8.

二级参考文献10

  • 1陈万群,骆婕,彭锐锐,吴颜晖,莫宏波,冯烈,李菊香,刘誉.SR-AⅡ和CD36的表达水平与AGEs及糖尿病并发症的相关性研究[J].中国病理生理杂志,2007,23(1):168-172. 被引量:15
  • 2Yan SF,Ramasamy R,Schmidt AM.Mechanisms of disease:advanced glycation end-products and their receptor in inflammation and diabetes complications[J].Nat Clin Pract Endocrinol Metab,2008,4(5):285-293.
  • 3Galler A,Muller G,Schinzel R,et al.Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes,as determined by fluorescence spectroscopy and nepsilon-carboxymethyl lysine ELISA[J].Diabetes Care,2003,26(9):2609-2615.
  • 4Hou FF,Ren H,Owen WF,et al.Enhanced expression of receptor for advanced glycation end products in chronic kidney disease[J].J Am Soc Nephrol,2004,15(7):1889-1896.
  • 5Gu L,Hagiwara S,Fan Q,et al.Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes[J].Nephrol Dial Transplant,2006,21(2):299-313.
  • 6Flyvbjerg A,Denner L,Schrijvers BF,et al.Long term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice[J].Diabetes,2004,53(1):166-172.
  • 7Bro S,Flyvbjerg A,Binder CJ,et al.A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice[J].Atherosclerosis,2008,201(2):274-280.
  • 8Jensen LJ,Denner L,Schrijvers BF,et al.Renal effects of a neutralising RAGE-antibody in long term streptozotocin-diabetic mice[J].J Endocrinol,2006,188(3):493-501.
  • 9卢梅,张风雷,高海青.糖基化终产物及其受体的靶向药物治疗进展[J].中国动脉硬化杂志,2008,16(7):575-578. 被引量:2
  • 10詹雅诗,冯烈.糖耐量异常与血管病变及糖基化终产物[J].中国病理生理杂志,2009,25(2):405-408. 被引量:7

共引文献4

同被引文献33

  • 1Goldfarb S, Ziyadeh FN. TGF-beta: a crucial component ofthe pathogenesis of diabetic nephropathy [J]. Trans Am ClinClimatol Assoc, 2001, 112(11) . 27-32,33.
  • 2Nakagawa H. Sasahara M, Haneda M, et al. Immunohisto-chemical characterization, of glomerular PDGF B-chain andPDGF beta-receptor expression in diabetic rats[J]. DiabetesRes Clin Pract, 2000, 48(2): 87-98.
  • 3Wang JJ, Zhang SX,Lu K, et al. Decreased expression ofpigment epithelium-derived factor is involved in the pathogene-sis of diabetic nephropathy [J]. Diabetes, 2005,54(1) : 243-250.
  • 4Kanesaki Y, Suzuki D, Uehara G, et al. Vascular endothelialgrowth factor gene expression is correlated with glomerularneovascularization in human diabetic nephropathy [J]. Am JKidney I.s, 2005,45(2): 288-294.
  • 5Zhang SX, Wang JJ, Gao G,et al. Pigment epithelium-de-rived factor downregulates vascular endothelial growth factor(VEGF) expression and inhibits VEGF-VEGF receptor2 bind-ing in diabetic retinopathy[J]. Mol Endocrinol, 2006, 37(1):1-12.
  • 6Li JJ, Kwak SJ,Jung DS. et al. Podocyte biology in diabeticnephropathy [J]. Kidney Int, 2007, 106: S36-S42.
  • 7Notari L,Baladron V. Aroca-Aguilar JD, et al. Identificationof a lipase-linked cell membrane receptor for pigment epitheli-um-derived factor[J]. J Biol Chem, 2006. 281 (49) : 38022-38037.
  • 8Ku CH,White KE, Dei Cas A,et al. Inducible overexpres-sion of sFlt-1 in podoctes ameliorates glomerulopathy in dia-betic mice[J]. Diabetes, 2008,57(10): 2824-2833.
  • 9Kosugi T,Nakayama T, Li Q,et al. Soluble Flt-1 gene thera-py ameliorates albuminuria but accelerates tubulointerstitial in-jury in diabetic mice[J], Am J Physiol Ren Physiol. 2010. 298(3): 609-616.
  • 10Ten Dijke P, Hill CS. New insights into TGF-beta-Smad sig-nalling [J]. Trends Biochem Sci. 2004,29(5) : 265-273.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部